These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6472329)

  • 1. Dominant lethal mutations induced in mouse spermatogonia by antineoplastic drugs.
    Goldstein LS
    Mutat Res; 1984 Aug; 140(4):193-7. PubMed ID: 6472329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dominant lethal mutations induced in mouse spermatogonia by mechlorethamine, procarbazine and vincristine administered in 2-drug and 3-drug combinations.
    Goldstein LS
    Mutat Res; 1987; 191(3-4):171-6. PubMed ID: 3627154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenesis in murine spermatogonia by MOPP therapy.
    Goldstein LS
    Reprod Toxicol; 1987-1988; 1(2):99-103. PubMed ID: 2980376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procarbazine-induced specific-locus mutations in male mice.
    Ehling UH; Neuhäuser A
    Mutat Res; 1979 Feb; 59(2):245-56. PubMed ID: 440322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of an in vitro technique to detect mutations induced by antineoplastic drugs in mouse germ cells.
    Goldstein LS
    Cancer Treat Rep; 1984 Jun; 68(6):855-8. PubMed ID: 6547366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophoretically detected germinal mutations induced in the mouse by ethylnitrosourea.
    Johnson FM; Lewis SE
    Proc Natl Acad Sci U S A; 1981 May; 78(5):3138-41. PubMed ID: 6942421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of specific-locus and dominant-lethal mutations by cyclophosphamide and combined cyclophosphamide-radiation treatment in male mice.
    Ehling UH; Neuhäuser-Klaus A
    Mutat Res; 1988 May; 199(1):21-30. PubMed ID: 3362160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dominant cataract and recessive specific-locus mutations detected in offspring of procarbazine-treated male mice.
    Kratochvilova J; Favor J; Neuhäuser-Klaus A
    Mutat Res; 1988 Apr; 198(2):295-301. PubMed ID: 3352637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the mutagenicity of methadone hydrochloride. Induced dominant lethal mutation and spermatocyte chromosomal aberrations in treated males.
    Badr FM; Rabouh SA; Badr RS
    Mutat Res; 1979 Nov; 68(3):235-49. PubMed ID: 514304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presumed gene mutations detected in F1 progeny of mouse males treated with ethyl methanesulfonate.
    Paschin YuV
    Mutat Res; 1990 Apr; 229(2):185-7. PubMed ID: 2320030
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effectiveness of using different radioprotectors for the protection of the sex cells of male mice from the genetic action of radiation, 1. Frequency study of dominant lethal mutations in postspermatogonial cells].
    Pomerantseva MD; Ramaĭia LK; Zherebchenko PG; Kalistratov GV
    Radiobiologiia; 1981; 21(5):722-9. PubMed ID: 7313092
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of dominant lethal mutations by Ascaris trypsin inhibitor in male mice.
    Blaszkowska J
    Reprod Toxicol; 2010 Jan; 29(1):113-9. PubMed ID: 19737609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action of N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide hydrochloride (procarbazine hydrochloride) in the germ tissue of mice: dominant lethal effects.
    Roberts GT; Johnson FM; Malling HV; Sharma RK
    Arch Toxicol; 1979 Feb; 41(4):287-94. PubMed ID: 435078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of specific-locus and dominant lethal mutations in male mice by busulfan.
    Ehling UH; Neuhäuser-Klaus A
    Mutat Res; 1991 Aug; 249(2):285-92. PubMed ID: 2072971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleomycin, unlike other male-mouse mutagens, is most effective in spermatogonia, inducing primarily deletions.
    Russell LB; Hunsicker PR; Kerley MK; Johnson DK; Shelby MD
    Mutat Res; 2000 Aug; 469(1):95-105. PubMed ID: 10946246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The frequency of dominant cataract and recessive specific-locus mutations in mice derived from 80 or 160 mg ethylnitrosourea per kg body weight treated spermatogonia.
    Favor J
    Mutat Res; 1986 Aug; 162(1):69-80. PubMed ID: 3724777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage-specific sensitivity of spermatogonia to different chemotherapeutic drugs.
    Meistrich ML
    Biomed Pharmacother; 1984; 38(3):137-42. PubMed ID: 6478053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dose dependencies of mutations of germ cells in mice].
    Eling UKh
    Tsitol Genet; 1986; 20(3):180-90. PubMed ID: 3750408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mutagenic effect of nitrosodimethylurea in male mice. Induction of dominant lethal mutations and chromosome aberrations in germ cells; genotype influence on the clastogenic effect in bone marrow cells].
    Malashenko AM; Beskova TB; Vasil'eva SV
    Genetika; 1997 Apr; 33(4):524-31. PubMed ID: 9206667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of specific-locus and dominant lethal mutations in male mice by trophosphamide.
    Ehling UH; Neuhäuser-Klaus A
    Mutat Res; 1994 May; 307(1):229-36. PubMed ID: 7513801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.